These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2269998)

  • 1. Assessment of efficacy of activated charcoal for treatment of acute T-2 toxin poisoning.
    Fricke RF; Jorge J
    J Toxicol Clin Toxicol; 1990; 28(4):421-31. PubMed ID: 2269998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of superactive charcoal in rats exposed to oral lethal doses of T-2 toxin.
    Galey FD; Lambert RJ; Busse M; Buck WB
    Toxicon; 1987; 25(5):493-9. PubMed ID: 3617086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of glucocorticoids and activated charcoal on the lethality of rats after acute poisoning with T-2 toxin, diacetoxyscirpenol, or roridin A.
    Hunder G; Fichtl B; Forth W
    Nat Toxins; 1994; 2(3):120-3. PubMed ID: 8087431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholestyramine as an adsorbent in acute lindane poisoning: a murine model.
    Kassner JT; Maher TJ; Hull KM; Woolf AD
    Ann Emerg Med; 1993 Sep; 22(9):1392-7. PubMed ID: 7689801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the clinical efficacy of activated charcoal.
    Watson WA
    Drug Intell Clin Pharm; 1987 Feb; 21(2):160-6. PubMed ID: 3549212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man.
    Olkkola KT
    Br J Clin Pharmacol; 1985 Jun; 19(6):767-73. PubMed ID: 4027120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a general therapeutic protocol for the treatment of acute T-2 toxicosis in swine.
    Poppenga RH; Lundeen GR; Beasley VR; Buck WB
    Vet Hum Toxicol; 1987 Jun; 29(3):237-9. PubMed ID: 3037764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of activated charcoal and magnesium citrate in the treatment of oral paraquat intoxication.
    Gaudreault P; Friedman PA; Lovejoy FH
    Ann Emerg Med; 1985 Feb; 14(2):123-5. PubMed ID: 3970396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated charcoal updated.
    Greensher J; Mofenson HC; Picchioni AL; Fallon P
    JACEP; 1979 Jul; 8(7):261-3. PubMed ID: 449159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does ethanol modify antidotal efficacy of oral activated charcoal studies in vitro and in experimental animals.
    Olkkola KT
    J Toxicol Clin Toxicol; 1984; 22(5):425-32. PubMed ID: 6530700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.
    Neuvonen PJ; Olkkola KT
    Med Toxicol Adverse Drug Exp; 1988; 3(1):33-58. PubMed ID: 3285126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Position paper: Single-dose activated charcoal.
    Chyka PA; Seger D; Krenzelok EP; Vale JA; ;
    Clin Toxicol (Phila); 2005; 43(2):61-87. PubMed ID: 15822758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of T-2 toxin-induced morphologic effects in the rat by highly activated charcoal.
    Bratich PM; Buck WB; Haschek WM
    Arch Toxicol; 1990; 64(3):251-3. PubMed ID: 2372237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose activated charcoal-backup and reassess.
    Seger D
    J Toxicol Clin Toxicol; 2004; 42(1):101-10. PubMed ID: 15083946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated charcoal administration in a pediatric emergency department.
    Osterhoudt KC; Alpern ER; Durbin D; Nadel F; Henretig FM
    Pediatr Emerg Care; 2004 Aug; 20(8):493-8. PubMed ID: 15295243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A "superactive" charcoal for antidotal use in poisonings.
    Cooney DO
    Clin Toxicol; 1977; 11(4):387-90. PubMed ID: 589951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of activated charcoal in acute poisonings: clinical safety and factors associated with adverse reactions in 575 cases].
    Amigó M; Nogué S; Miró O
    Med Clin (Barc); 2010 Jul; 135(6):243-9. PubMed ID: 20537361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of protective efficacy of CC-2 formulation against topical lethal dose of T-2 toxin in mice.
    Agrawal M; Pardasani D; Lakshmana Rao PV
    Food Chem Toxicol; 2012 Mar; 50(3-4):1098-108. PubMed ID: 22245378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of intoxications using single and repeated doses of oral activated charcoal.
    Olkkola KT; Neuvonen PJ
    J Toxicol Clin Exp; 1989; 9(4):265-75. PubMed ID: 2696790
    [No Abstract]   [Full Text] [Related]  

  • 20. An
    Tomoda Y; Kobayashi M
    Clin Toxicol (Phila); 2024 Apr; 62(4):237-241. PubMed ID: 38646866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.